Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment

NCT02460133 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C Virus

Interventions

DRUG: Paritaprevir
DRUG: Ritonavir
DRUG: Dasabuvir
DRUG: Ombitasvir
DRUG: Ribavirin

Sponsor

Nova Scotia Health Authority

Collaborators

[object Object]